Salicylate, an active metabolite of the non-steroidal anti-inflammatory drug (NSAID) aspirin, can reverse HFD-induced obesity and insulin resistance by the inhibition of nuclear factor kappa B (NF-κB) (Yuan et al., 2001). Here, NFKB1 is linked to Obesity.